Shicheng Yang

Author PubWeight™ 14.26^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity.	J Immunol	2009	2.43
2	Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies.	Crit Rev Ther Drug Carrier Syst	2004	2.06
3	Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy.	Blood	2010	2.01
4	B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma.	Clin Cancer Res	2013	1.60
5	Improving adoptive T cell therapy by targeting and controlling IL-12 expression to the tumor environment.	Mol Ther	2011	1.36
6	Mice deficient for testis-brain RNA-binding protein exhibit a coordinate loss of TRAX, reduced fertility, altered gene expression in the brain, and behavioral changes.	Mol Cell Biol	2003	1.19
7	Risk score for the prediction of contrast-induced nephropathy in elderly patients undergoing percutaneous coronary intervention.	Angiology	2012	1.06
8	Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies.	J Immunother	2011	1.04
9	Lentiviral vector design for optimal T cell receptor gene expression in the transduction of peripheral blood lymphocytes and tumor-infiltrating lymphocytes.	Hum Gene Ther	2009	1.00
10	Irradiation enhances human T-cell function by upregulating CD70 expression on antigen-presenting cells in vitro.	J Immunother	2011	0.83
11	Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy: A meta-analysis of 15 randomized controlled trials.	Medicine (Baltimore)	2017	0.75